Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cardiovascular and renal agents from SB act as endothelin antagonists

Nov. 16, 1999

Cardioprotective ginkgolides under study at CNRS

Nov. 16, 1999

Favorable phase II results announced for Valentis's VEGF165 gene medicine at AHA

Nov. 15, 1999

Mechanism of antioxidant action of S-17834 explored in vitro

Nov. 15, 1999

AstraZeneca's immunomodulator H-327/86 is a novel candidate for treating atherosclerosis

Nov. 15, 1999

United Therapeutics completes enrollment in phase III pulmonary hypertension trial

Nov. 12, 1999

Synergistic effects Na+/H+ exchange inhibitor and K(ATP) channel opener in MI

Nov. 11, 1999

ELITE II fails to confirm results of ELITE; Merck drops HF indication for Cozaar

Nov. 11, 1999

Clinical results for Enbrel in heart failure presented at AHA Scientific Sessions

Nov. 11, 1999

Heart Failure: Beyond Y2K -- a Prous Science webcast from the AHA

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...